Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
Planta Med ; 88(13): 1223-1232, 2022 Oct.
Article in English | MEDLINE | ID: mdl-34715694

ABSTRACT

Cannabis sativa is a millenary medicinal plant. However, contrary to worldwide paradigm-shifting, countries like Brazil still prohibit C. sativa cultivation and its medicinal use, even though many populations use aerial parts and roots of this plant for healthcare. As such, the objective of this work was to identify substances in the samples of the C. sativa roots, tracing a correlation with antitussive and expectorant effects. Therefore, samples of C. sativa roots were donated by the Polícia Federal Brasileira, and its aqueous extract (AECsR) was prepared with subsequent lyophilization, to maintain the material stability. After that, the material was analyzed by LC-MS to observe its chemical profile. Four samples (AECsR-A, B, C, and D) were tested in animal models of citric acid-induced cough (0.4 M) and phenol red expectoration (500 mg/kg). Using LC-MS it was possible to identify 5 molecules in C. sativa roots: p-coumaroyltyramine, tetrahydrocannabinol-C4, feruoiltyramine, anhydrocanabisativine, and cannabisativine. In experimental protocols, male mice (Mus musculus) were treated with samples of AECsR at doses of 12.5, 25, or 50 mg/kg regardless of the pharmacological test. In these tests, all samples showed the potential to treat cough and promote fluid expectoration, differing only in the dose at which these effects were observed. Therefore, the data showed that the C. sativa roots of the Brazilian Northeast showed antitussive and expectorant effects, even with intense secondary metabolites' variation, which alters its potency, but not its effect. This highlights the importance of this medicinal plant for future therapy and corroborates to traditional use.


Subject(s)
Antitussive Agents , Cannabis , Plants, Medicinal , Mice , Animals , Antitussive Agents/pharmacology , Antitussive Agents/therapeutic use , Expectorants/pharmacology , Expectorants/therapeutic use , Cough/chemically induced , Cough/drug therapy , Brazil , Phenolsulfonphthalein , Chromatography, Liquid , Dronabinol/therapeutic use , Tandem Mass Spectrometry , Plants, Medicinal/chemistry , Citric Acid/toxicity , Citric Acid/therapeutic use
2.
J Ethnopharmacol ; 278: 114259, 2021 Oct 05.
Article in English | MEDLINE | ID: mdl-34058314

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Many studies are performed with the aerial parts of Cannabis sativa L. (Cannabaceae). However, roots remain poorly studied, despite citations in the scientific literature. The C. sativa roots are indicated for the treatment of pain, inflammation, fever, among other health problems. AIM OF THE STUDY: This study aimed to evaluate the antinociceptive, antipyretic, antiasthmatic, and spasmolytic activities of C. sativa roots in experimental models using mice and rats. MATERIAL AND METHODS: The chemical composition of the aqueous extract of C. sativa roots (AECsR) was evaluated by LC-MS. The antinociceptive activity was assessed in mice by the induction of writhing with acetic acid, paw licking with formalin, and reactivity in the hot plate test. Fever was induced by the administration of a suspension of Saccharomyces cerevisiae in young rats. The asthmatic activity was performed with ovalbumin (OVA)-immunized mice with cellular and histological analysis. Finally, the spasmolytic activity was performed using mice isolated trachea. For in vivo studies, the doses were 12.5, 25, or 50 mg/kg whereas for in vitro, the concentration of AECsR was 729 µg/mL. RESULTS: From the LC-MS data, we identified p-coumaroyltyramine, feruloyltyramine canabissativine in AECsR. The extract promoted a reduction of writhing in all tested doses (12.5, 25, or 50 mg/kg). Similarly, it reduced the pain in the formalin test at doses of 12.5 and 50 mg/kg (first phase) and 12.5 and 25 mg/kg (second phase). In the hot plate test, the doses of 12.5, 25, and 50 mg/kg promoted antinociceptive effect at different times, and the lowest dose maintained its action in the analyzes performed at 60, 90, and 120 min after administration. The anti-inflammatory activity of AECsR was observed in the mouse model of asthma, reducing the total leukocyte count in the bronchoalveolar fluid (BALF) at a dose of 25 mg/kg, as well as reducing eosinophilia in all tested doses (12.5, 25, and 50 mg/kg). Histological analysis of lungs stained with H&E and PAS showed a reduction in the number of inflammatory cells in the perivascular and peribronchial region, as well as reduced mucus production. CONCLUSION: The results suggest that AECsR promotes pain control, either by a central or inflammatory mechanism, and has antiasthmatic activity. However, there was no antipyretic or spasmolytic effect.


Subject(s)
Analgesics/pharmacology , Anti-Asthmatic Agents/pharmacology , Cannabis/chemistry , Plant Extracts/pharmacology , Analgesics/administration & dosage , Analgesics/isolation & purification , Animals , Anti-Asthmatic Agents/administration & dosage , Anti-Asthmatic Agents/isolation & purification , Antipyretics/administration & dosage , Antipyretics/isolation & purification , Antipyretics/pharmacology , Brazil , Disease Models, Animal , Dose-Response Relationship, Drug , Fever/drug therapy , Inflammation/drug therapy , Male , Mice , Pain/drug therapy , Parasympatholytics/administration & dosage , Parasympatholytics/isolation & purification , Parasympatholytics/pharmacology , Plant Extracts/administration & dosage , Plant Roots , Rats , Rats, Wistar
3.
J Ethnopharmacol ; 271: 113868, 2021 May 10.
Article in English | MEDLINE | ID: mdl-33503453

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: There are many studies and therapeutic properties attributed to the flowers and leaves of the Cannabis species, but even with few pharmacological studies, Cannabis sativa L. (Cannabaceae) roots presents several therapeutic indications in folk medicine. AIM OF THE STUDY: This study aimed to evaluate the anti-inflammatory and spasmolytic effects as well as the toxicological profile of the aqueous extract of Cannabis sativa roots (CsAqEx) in mice. MATERIALS AND METHODS: We assessed the anti-inflammatory effect with carrageenan-induced leukocyte migration assay, and carrageenan and histamine-induced paw edema methods; The spasmolytic effect was assessed through in vitro assays with isolated mice trachea. To assess motor coordination and mobility, mice went through the rotarod and open field tests, respectively. For the single-dose toxicity study, we administered CsAqEx at the dose of 1000 mg/kg by gavage. In a repeated dose toxicity study, animals received CsAqEx at doses of 25 mg or 100 mg/kg for 28 days. RESULTS: The CsAqEx inhibited the migration of leukocytes at the doses of 25, 50, and 100 mg/kg. The CsAqEx showed anti-inflammatory activity after the intraplantar injection of carrageenan, presenting a reduction in edema formation at all tested doses (12.5, 25, 50 and 100 mg/kg). The dose of 12.5 mg/kg of CsAqEx prevented edema formation after intraplantar injection of histamine. In an organ bath, 729 µg/mL of CsAqEx did not promote spasmolytic effect on isolated mice tracheal rings contracted by carbachol (CCh) or potassium chloride (KCl). We did not observe clinical signs of toxicity in the animals after acute treatment with CsAqEx, which suggested that the median lethal dose (LD50) is greater than 1000 mg/kg. Repeated dose exposure to the CsAqEx did not produce significant changes in hematological, biochemical, or organ histology parameters. CONCLUSIONS: The results suggest that the anti-inflammatory effect of CsAqEx is related to the reduction of vascular extravasation and migration of inflammatory cells, without effects on the central nervous system. Moreover, there was no spasmolytic effect on airway smooth muscle and no toxicity was observed on mice.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/toxicity , Cannabis/chemistry , Parasympatholytics/pharmacology , Parasympatholytics/toxicity , Plant Extracts/pharmacology , Plant Extracts/toxicity , Administration, Oral , Animals , Anti-Inflammatory Agents/administration & dosage , Behavior, Animal/drug effects , Carrageenan/toxicity , Edema/chemically induced , Edema/prevention & control , Histamine/toxicity , Inflammation/chemically induced , Inflammation/prevention & control , Kidney/drug effects , Kidney/pathology , Liver/drug effects , Liver/pathology , Mice , Muscle, Smooth/drug effects , Open Field Test/drug effects , Parasympatholytics/administration & dosage , Plant Extracts/administration & dosage , Plant Roots/chemistry , Psychomotor Performance/drug effects , Rotarod Performance Test , Stomach/drug effects , Stomach/pathology , Trachea/drug effects
4.
J Ethnopharmacol ; 259: 112952, 2020 Sep 15.
Article in English | MEDLINE | ID: mdl-32416247

ABSTRACT

ETHNOPHARMACOLOGY RELEVANCE: Schinus terebinthifolia Raddi leaves have been used in folk medicine due to several properties, including antitumor and analgesic effects. The variable efficacy and adverse effects of analgesic drugs have motivated the search for novel antinociceptive agents. It has been reported that the S. terebinthifolia leaf lectin (SteLL) has antitumor activity against sarcoma 180 in mice. AIM OF THE STUDY: This work aimed to evaluate whether SteLL would reduce cancer pain using an orthotopic tumor model. MATERIALS AND METHODS: A sarcoma 180 cell suspension was inoculated into the right hind paws of mice, and the treatments (150 mM NaCl, negative control; 10 mg/kg morphine, positive control; or SteLL at 1 and 2 mg/kg) were administered intraperitoneally 24 h after cell inoculation up to 14 days. Spontaneous nociception, mechanical hyperalgesia, and hot-plate tests were performed. Further, the volume and weight of the tumor-bearing paws were measured. RESULTS: SteLL (2 mg/kg) improved limb use during ambulation. The lectin (1 and 2 mg/kg) also inhibited mechanical hyperalgesia and increased the latency time during the hot-plate test. Naloxone was found to reverse this effect, indicating the involvement of opioid receptors. The tumor-bearing paws of mice treated with SteLL exhibited lower volume and weight. CONCLUSION: SteLL reduced hyperalgesia due to sarcoma 180 in the paws of mice, and this effect can be related to its antitumor action.


Subject(s)
Anacardiaceae , Analgesics/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Cancer Pain/prevention & control , Hyperalgesia/prevention & control , Nociceptive Pain/prevention & control , Plant Leaves , Plant Lectins/pharmacology , Sarcoma 180/drug therapy , Anacardiaceae/chemistry , Analgesics/isolation & purification , Animals , Antineoplastic Agents, Phytogenic/isolation & purification , Cancer Pain/etiology , Cancer Pain/metabolism , Cancer Pain/physiopathology , Female , Hyperalgesia/etiology , Hyperalgesia/metabolism , Hyperalgesia/physiopathology , Mice , Nociception/drug effects , Nociceptive Pain/etiology , Nociceptive Pain/metabolism , Nociceptive Pain/physiopathology , Pain Threshold/drug effects , Plant Leaves/chemistry , Plant Lectins/isolation & purification , Reaction Time/drug effects , Receptors, Opioid/metabolism , Sarcoma 180/complications , Sarcoma 180/pathology , Signal Transduction , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL